Cardiac Arrest – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033
Cardiopulmonary arrest (CPA) refers to the halt of adequate ventilation and circulation, also known as cardiac or circulatory arrest. In adults, it commonly stems from a primary cardiac event. Ventricular fibrillation (VF) accounts for 50 to 80% of cases, with Pulseless electrical activity (PEA) and asystole comprising 20 to 30%. Pulseless sustained ventricular tachycardia (VT) is less frequent but still notable. Without prompt intervention, CPA can lead to sudden death. However, it can be reversed through cardiopulmonary resuscitation (CPR), cardioversion/defibrillation, or cardiac pacing. Early initiation of CPR and cardiac monitoring helps determine the appropriate intervention. In the U.S., over 400,000 individuals succumb to CPA annually. Thelansis’s “Cardiac Arrest Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive l...